AwardedAwarded 4 November 2026
Fibroscanner Lease
The Newcastle Upon Tyne Hospitals NHS Foundation Trust · NHS and health
In brief
The Newcastle Upon Tyne Hospitals NHS Foundation Trust awarded medical supplies work to Echosens UK Limited on 4 November 2026.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
The Newcastle upon Tyne Hospitals NHS Foundation Trust provides comprehensive Fibroscanning services, establishing a non-invasive, gold-standard clinical pathway for staging liver fibrosis and monitoring liver disease progression. Virtually all patients
attending an outpatient hepatology clinic at the Freeman Hospital require a Fibroscan to safely manage their care.
The Trust is intending to award directly to Echosens for a 36 month lease of two Fibroscanners plus maintenance under Schedule 5, paragraph 2 of the Procurement Act 2023.
Direct award justification:
Single supplier - intellectual property or exclusive rights
Single supplier - technical reasons
The equipment manufacturer, Echosens, is the exclusive, sole-source global provider of this specific diagnostic technology
Who won
| Winner | Value | Dates |
|---|---|---|
| Echosens UK Limited (SME) | £151,560 | Awarded 4 November 2026 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Transparency notice · UK5, notice 080032-2026
- Contract award notice · UK6, notice 104652-2026
About the buyer
The Newcastle Upon Tyne Hospitals NHS Foundation TrustLast 12 months
Procurements
59Awards
41Suppliers it has used most for medical supplies
- Abiomed1 contract
- B. Braun Medical Limited1 contract
- Bayer Public Limited Company1 contract
- Becton, Dickinson U.K. Limited1 contract
- Echosens UK Limited1 contract
Similar open tenders
All open medical supplies tenders- £173kframework ceiling
- £173kframework ceiling
- £6.86mframework ceiling
From notice 080032-2026 on Find a Tender, first published 21 August 2026, last updated 4 November 2026. We last checked for changes on 4 November 2026.